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Abstract
Background: Sickle cell disease (SCD) leads to tissue hypoxia resulting in chronic organ dysfunction including SCD
associated nephropathy. The goal of our study was to determine the best equation to estimate glomerular filtration
rate (GFR) in SCD adult patients.
Methods: We conducted a prospective observational cohort study. Since 2007, all adult SCD patients in steady
state, followed in two medical departments, have had their GFR measured using iohexol plasma clearance (gold
standard). The Cockcroft-Gault, MDRD-v4, CKP-EPI and finally, MDRD and CKD-EPI equations without adjustment for
ethnicity were tested to estimate GFR from serum creatinine. Estimated GFRs were compared to measured GFRs
according to the graphical Bland and Altman method.
Results: Sixty-four SCD patients (16 men, median age 27.5 years [range 18.0-67.5], 41 with SS-genotype were
studied. They were Sub-Saharan Africa and French West Indies natives and predominantly lean (median body mass
index: 22 kg/m2 [16-33]). Hyperfiltration (defined as measured GFR >110 mL/min/1.73 m2) was detected in 53.1% of
patients. Urinary albumin/creatinine ratio was higher in patients with hyperfiltration than in patients with normal
GFR (4.05 mg/mmol [0.14-60] versus 0.4 mg/mmol [0.7-81], p = 0.01). The CKD-EPI equation without adjustment for
ethnicity had both the lowest bias and the greatest precision. Differences between estimated GFRs using the CKP-
EPI equation and measured GFRs decreased with increasing GFR values, whereas it increased with the Cockcroft-
Gault and MDRD-v4 equations.
Conclusions: We confirm that SCD patients have a high rate of glomerular hyperfiltration, which is frequently
associated with microalbuminuria or macroalbuminuria. In non-Afro-American SCD patients, the best method for
estimating GFR from serum creatinine is the CKD-EPI equation without adjustment for ethnicity. This equation is
particularly accurate to estimate high GFR values, including glomerular hyperfiltration, and thus should be
recommended to screen SCD adult patients at high risk for SCD nephropathy.
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Iohexol plasma clearance, Ethnicity
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Background
Sickle cell disease (SCD) is one of the most common
genetic hemoglobinopathies in which sickle hemoglobin
leads to tissue hypoxia causing acute tissue damage
and chronic organ dysfunction including SCD asso-
ciated nephropathy [1]. Four genotypes—sickle cell
anemia (HbSS), sickle-hemoglobin C disease (HbSC), and
two types of sickle-β-thalassemia (Sβ + −thalassemia
and Sβo-thalassemia)—account for most cases of SCD.
Compared to patients with other genotypes, those
with a homozygous SS genotype have more profound
anemia and higher morbidity and mortality [1,2]. SCD
mainly affects natives of Sub-Saharan Africa, the West
Indies, India, and South-America. Because of past and
more recent migratory movements and thanks to bet-
ter care in childhood, SCD has become a real health
issue in European countries and especially in France
where more than 7000 subjects are affected, half of
whom are adults [2]. Glomerular hyperfiltration seems
to be one of the first steps of SCD associated nephro-
pathy, as in type I diabetes mellitus associated
nephropathy [3], and is a frequent feature in young
adult SCD patients [4,5]. Considering the negative im-
pact of SCD associated nephropathy on the prognosis
and the potential interest of an early nephroprotective
treatment with angiotensin converting enzyme (ACE)
inhibitors [1,6,7], an accurate screening of glomerular
hyperfiltration is essential. CKD-EPI, a new equation
to estimate glomerular filtration rate (GFR) from
serum creatinine, has been reported to be particularly
accurate to estimate high levels of GFR [8] but has
never been evaluated in SCD patients.
The main objective of our study was to determine the
best equation to estimate GFR in SCD adult patients
using five different equations. We also aimed at deter-
mining the prevalence of hyperfiltration and albuminuria
among these patients and the relationship between albu-
minuria and GFR.
Methods
Patients
We conducted a prospective observational cohort study.
Since January 2007, all newly referred SCD adult
patients seen in two medical departments have had a
comprehensive work-up including GFR measurement.
At the time of investigation, all patients had to have
been in steady state for at least three months (no acute
illness, no vaso-occlusive crisis, no acute chest syn-
drome, and no urinary tract infection). Pregnant and
breast feeding women, patients allergic to iodine,
patients with diabetes mellitus, hypertension or other
diseases susceptible to induce chronic kidney disease
were not eligible for the present study. The study proto-
col conforms to the ethical guidelines of the 1975
Declaration of Helsinki and was approved by a local
ethic committee (Comité de Protection des Personnes,
Ile de France II) and received the number 2011531-
RCEB.
Glomerular filtration rate measurement
All patients underwent direct measurement of GFR
using plasma clearance of iohexol, an exogenous marker,
as previously described [9]. All patients received a 5 mL
intravenous dose of iohexol. Each patient then simultan-
eously ingested 150 mL of water within 30 minutes.
Blood samples were taken at 0, 60, 120, 180, 240, and
300 minutes after injection. Clearance of iohexol was
calculated by the following formula: Clearance =Dose/
AUC, where AUC is the area under the plasma concen-
tration curve.
Measured GFR (mGFR) was normalized in mL/mi-
nute/1.73 m2 by using the Dubois formula for the calcu-
lation of BSA (body surface area) [10].
BSA m2
 
¼ 0; 0071184 height0;725  weight0;425
Since there is no consensus to define glomerular
hyperfiltration we chose to define glomerular hyperfiltra-
tion as mGFR higher than 110 mL/min/1.73 m2, as did
Haymann et al. [5].
Biological measurements
Other biological measurements included hemoglobin
and reticulocyte counts, serum creatinine, and urinary
albumin excretion rate (AER) on a single urinary spot
expressed as mg/mmol urinary creatinine. AER was
categorized as normoalbuminuria (AER < 3 mg/mmol),
microalbuminuria (AER from 3 to 30 mg/mmol), or
macroalbuminuria (AER > 30 mg/mmol). All measure-
ments were made using standard hospital laboratory
methods. Serum and urine creatinine were measured
by using an alkaline picrate rate-blanked compensated
kinetic assay (Hitachi 917 analyzer; Roche Diagnos-
tics) with standardization to isotope dilution mass
spectrometry.
Equations used to estimate GFR
MDRD-v4
(Four variables Modification of Diet in Renal Disease
equation) [11].
GFR mL=min=1:73 m2
 
¼ 175
 plasma creatinine μmol=1ð Þ=88:4½ 1:154
n o
age yearsð Þ0:203
0:742 if femaleð Þ  1:212 if blackð Þ
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MDRD without adjustment for ethnicity
GFR mL=min=1:73 m2
 
¼ 175
 plasma creatinine μmol=lð Þ = 88:4½ 1:154
n o
age yearsð Þ0:203  0:742 if femaleð Þ
CKD-EPI [12]
The CKD-EPI (Chronic Kidney Disease Epidemiology
Collaboration) equation, expressed as a single equation,
is: ‘GFR mL=min=1:73 m2ð Þ ¼ 141min Scr=k; 1ð Þα 
max Scr=k; 1ð Þ1:2090:993Age1:018 if femaleð Þ 1:159
if blackð Þ , where Scr is serum creatinine, k is 0.7 for
females and 0.9 for males, α is −0.329 for females and
−0.411 for males, min indicates the minimum of Scr/k
or 1, and max indicates the maximum of Scr/k or 1.’
CKD-EPI without adjustment for ethnicity
GFR mL=min=1:73 m2
 
¼ 141min Scr=k; 1ð Þα
max Scr=k; 1ð Þ1:209  0:993Age  1:018 if femaleð Þ
The MDRD-v4- and CKD-EPI-derived eGFRs with or
without adjustment for ethnicity are expressed as mL/
min/1.73 m2 because the equations were derived by
comparison with iothalamate-measured GFR, which it-
self is expressed as mL/min/1.73 m2.
Modified Cockcroft–Gault [13]
GFR mL=minð Þ for males ¼ gX 140 ageð ÞX weight kgð Þ½ 
=plasma creatinine μmol=lð Þ;
Where g = 1.23 for males and 1.04 for females.
Estimated GFR derived by using the Cockcroft–Gault
equation was converted from mL/min to mL/min/
1.73 m2 by multiplying calculated values by 1.73, and
dividing by BSA.
Statistical methods
Agreement between GFR estimated using the different
equations described above and GFR measurement by
iohexol plasma clearance (reference method) was
assessed graphically by plotting the difference in GFR
(estimated GFR - GFR measured by the reference
method) against the mean GFR, where mean GFR is
(GFR measured by the reference method + estimated
GFR)/2), according to the method described by Bland
and Altman [14]. Bias was estimated by the mean differ-
ence in GFR and limits of agreement defined by the
mean difference ± 1.96 standard deviations of the differ-
ence (SD).
Percentages were compared using the CHI-squared
test, or the Fisher test, as appropriate.
Distributions were estimated using a kernel density distri-
bution. Bandwith selection was done using the Sheather-
Jones method [15]. Calculations were made using the the
KDE procedure of the SAS statistical software.
Several means were compared using the Kruskall-
Wallis method (more than 2 groups) or the Mann–
Whitney test (two groups). Differences were assessed
using the paired t test. A p value less than 0.05 was con-
sidered significant.
In order to assess relationships between relevant quan-
titative variables, we used the Pearson correlation coeffi-
cient. Calculations were performed using the Statview
Statistical and the SAS statistical software version 9.2.
Results
Description of the population and of SCD associated
nephropathy
From January 2007 to December 2008, 67 consecutive
adult SCD patients were studied. Three patients were
excluded, including one with diabetes mellitus and two
with hypertension. Finally, 64 patients were included in
the present study: 41 with SS genotype, 15 with SC
genotype, 7 with Sβ genotype, and 1 with SD genotype.
Table 1 summarizes the main clinical and biological
characteristics of the patients. They were predominantly
young and lean (median body mass index (BMI): 22 kg/
m2, range [16-33]). Most of them were native either of
Sub-Saharan Africa or of the French West Indies.
Thirty-four patients (53.1%) had hyperfiltration (defined
as measured GFR (mGFR) >110 mL/min/1.73 m2).
Measured GFR non-indexed for BSA was comparable
to mGFR expressed per BSA (mGFR non-indexed
BSA= 110.3 mL/min (median, 26.8-167.9); mGFR
expressed per BSA= 112.5 mL/min/1.73 m2 (29–183);
p = 0.2). Hyperfiltration was more common in patients
with SS genotype than among those with non-SS geno-
type (p = 0.0017) (Table 1). Only one patient (a 48-year-
old female with SC-genotype) had a GFR <60 mL/min/
1.73 m2. Microalbuminuria or macroalbuminuria were
found in 36% and 14% of the patients, respectively. As
shown in Table 1, the median urinary albumin/creatin-
ine ratio was significantly higher in patients with hyper-
filtration than in patients with normal or low mGFR
(4.05 mg/mmol [0.14-60] versus 0.4 mg/mmol [0.7-81],
p = 0.01). As shown in Table 2, when measured GFR is
divided into quartiles, the median urinary albumin/cre-
atinine ratio was the lowest for the second quartile of
mGFR and significantly increased for mGFR above
112 mL/min/1.73 m2 (p = 0.029).
Determination of the best equation to estimate GFR from
plasma creatinine in adult patients with SCD
Bland and Altman graphs are presented in Figure 1. In
our adult SCD population, all equations overestimate
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GFR compared to mGFR by iohexol plasma clearance
(p < 0.05, paired t-test). Moreover, the wide limits of
agreement (Table 3) suggest that large discrepancies be-
tween equations and mGFR can be observed. Distribu-
tions of measured GFR and estimated GFRs using a
kernel density distribution were represented in Figure 2
and confirm this previous point. Compared to the Cock-
croft and Gault and MDRD-v4 equations, the CKD-EPI
equation had both the lowest bias and the narrowest
limits of agreement. The difference between estimated
GFR calculated with the CKD-EPI equation and mGFR
decreases with increasing GFR values (r =− 0.23,
p = 0.06). In addition, we observed a significant relation-
ship between the difference and the mean for both the
Cockcroft and Gault (r = 0.34, p < 0.05) and the MDRD-
v4 equations (r = 0.68, p < 0.001). This means that the
difference between estimated GFR and mGFR (gold
standard) increases with increasing GFR values.
The MDRD-v4 and CKD-EPI equations comprise four
variables: age, sex, plasma creatinine and White/African-
American ethnic group. The patients of our study popu-
lation were mainly natives of Sub-Saharan African
Table 1 Characteristics of the studied population
Whole population
(n = 64)
Patients with SS
genotype (n = 41)
Patients with non-
SS genotype (n= 23)
p value * SS vs
non-SS
(n = 64) (n = 41) (n = 23)
Sex ratio (M/F), (M%) 16/48 (25.0%) 11/30 (27%) 5/18 (22%) 0.22
Age, years 27.5 [18–67.5] 26.8 [18–49.5] 31.7 [18–67.5] 0.03
Ethnical origin 0.74
Sub Saharian Africa 48 (75%) 32 (78.1%) 16 (69.6%)
French West Indies 10 (15.6%) 6 (14.6%) 4 (17.4%)
Maghreb 2 (3.1%) 1 (2.4%) 1 (4.3%)
Other 4 (6.3%) 2 (4.9%) 2 (8.7%)
Height, m 1.67 [1.48-1.83] 1.68 [1.53-1.83] 1.66 [1.48-1.78] 0.27
Weight, kg 63 [43.5-90] 61.5 [43.5-81] 64 [45–90] 0.03
Body mass index, kg/m2 22 [16–33] 21 [16–30] 24 [16–33)] 0.017
Hemoglobin, g/dL 8.9 [5.5-14.3] 8.2 [5.5-12.6] 10.7 [7.5-14.3] <0.001
Reticulocyte count, ×103/mm3 170 [32–466] 219 [32–466] 99 [34–271] <0.001
Plasma creatinine, μmol/L 55 [27–113] 48 [27–76] 65 [51–113] <0.001
mGFR, mL/min/1,73 m2 112.5 [29–183] 119 [65–183] 98 [29–163] <0.002
GFR >110 mL/min/1,73 m2 34 (53.1%) 28 (68.3%) 6 (26.1%) 0,0017
Urinary albumin/creatinine, mg/mmol 2.87 [0.07-134] 4.84 [0.14-80.6] 0.63 [0.07-134] 0.005
No albuminuria (<3 mg/mmol) 32 (50%) 16 (39%) 16 (69.5%)
Microalbuminuria 23 (36%) 17 (41.5%) 6 (26.1%)
Macroalbuminuria (>30 mg/mmol) 9 (14%) 8 (19.5%) 1 (4.3%) 0 .053
Results are expressed as numbers (%) or median [range].
M: male, F: female,
mGFR: glomerular filtration rate measured by iohexol plasma clearance.
* Tests are either Chi-square or Fisher’s exact test for categorical variables or Kruskall-Wallis test (more than two groups) or the Mann–Whitney test (two groups)
for continuous variables.
Table 2 Urinary albumin/creatinine ratio according to measured glomerular filtration rate (mGFR) divided into
quartiles
mGFR Quartile range
(mL/min/1.73 m2)
Median within the quartile (mL/min/1.73 m2) Urinary albumin/creatinine ratio, (mg/mmol) p value*
Quartile 1 [29–75] 74.5 1.86 [0.23-134.24] 0.029
Quartile 2 [96–112] 105 0.405 [0.07-80.63]
Quartile 3 [113–128] 119 3.04 [0.14-31.47]
Quartile 4 [129–183] 145 8.43 [0.36-59.77]
mGFR: glomerular filtration rate measured by iohexol plasma clearance.
Q1, Q2, Q3, Q4: each quartile of mGFR.
* p value was calculated using a Kruskal-Wallis test. Results are expressed as median [range].
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countries and of the French West Indies. None of our
patients was of African-American origin. Consequently,
the adjustment for racial group was not considered ap-
propriate for our population. Therefore, we removed
ethnicity from these two equations. Without this variable
(Figures 1D and 1E), overestimation decreased for both
MDRD-v4 and CKD-EPI whereas limits of agreement
remained comparable. Among the five equations tested
to estimate GFR, the CKD-EPI equation without adjust-
ment for ethnic group had both the lowest bias and the
narrowest limits of agreement. Finally, for the CKD-EPI
equation without adjustment for ethnic group, the differ-
ence with the gold standard decreased with increasing
GFR values (r =− 0.43, p < 0.001), whereas this difference
increased for the MDRD equation without adjustment
for ethnic group (r = 0.538, p < 0.001).
Discussion
Our study shows that the CKD-EPI equation without
the adjustment for African-American ethnicity is the
best equation to estimate GFR from serum creatinine in
adult SCD originating from Sub-Saharan Africa and the
French West Indies. It also confirms the high prevalence
of hyperfiltration among these patients and its associ-
ation with increased urinary albumin excretion rate.
Recently, Haymann et al.. have reported that the
MDRD-v4 equation was a more robust predictor of
hyperfiltration compared to the Cockcroft and Gault
estimated GFR in a cohort of adult SCD patients, al-
though the MDRD-v4 equation systematically overesti-
mated measured GFR [5]. In our study, we clearly show
that the MDRD-v4 equation has both the highest bias
and the lowest precision, followed by the Cockcroft and
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Figure 1 Bland and Altman plots for glomerular filtration rate (GFR) estimated with different equations compared to measured GFR.
Each graph is a Bland and Altman plot comparing a specific equation used for GFR estimation to the reference method (GFR measured using
iohexol plasma clearance). Mean GFR is calculated as follows: Mean GFR= (measured GFR+ estimated GFR)/2. The plain line represents the mean
difference between estimated GFR (eGFR) and GFR measured using the reference method (mGFR). In the grey zone, eGFR is lower than mGFR.
Dashed lines represent ± 1.96 SD. Results are expressed as mL/min/1.73 m2.
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Gault equation and lastly by the CKD-EPI equation, not
assessed in the study by Haymann et al.. [5]. In the MDRD
study [11,16], the MDRD-v4 equation was found to be ac-
curate in predicting GFR for values <60 mL/min/1.73 m2
whereas the CKD-EPI equation was shown to be as accur-
ate as MDRD in the subgroup with estimated GFR
<60 mL/min/1.73 m2 and substantially more accurate in
the subgroup with estimated GFR >60 mL/min/1.73 m2
[12,17,18]. The better performance of the CKD-EPI equa-
tion in this specific SCD population is thus expected at
least in part because many such patients have normal or
high GFR [12].
We also showed that both the MDRD-v4 and the
CKD-EPI equations gave better estimation of GFR after
excluding the correction for ethnicity. Finally, among
the five equations tested, the CKD-EPI equation without
adjustment for ethnicity was the most accurate to esti-
mate GFR in our population. The correction of esti-
mated GFR for black people by multiplying estimated
GFR by 1.212 for the MDRD-v4 equation [11] and by
Table 3 Mean difference (95% CI) and median difference [IQR] between each method of glomerular filtration rate
(GFR) estimation and measured GFR
Method of estimation Mean difference 95% Confidence interval p
value*
Median [IQR]
Cockcroft–Gault 45.3 26.8 to 41.3 <0.0001
38.9 [20.5-63.8]
CKD-EPI 30.2 25.8 t o 35.2 <0.0001
30.5 [16.5-44.3]
CKD-EPI without adjustment for ethnicity 10.7 5.8 to 15.7 <0.0001
12.8 [−0.7-24.8]
MDRD-v4 48.7 40.0 to 58.4 <0.0001
49.3 [24.7-64.8]
MDRD without adjustment for ethnicity 20.7 12.9 to 28.5 <0.0001
19.9 [4.9-32.9]
Results are expressed as mL/min/1.73 m2.
IQR: Inter Quartile Range.
CKD: Chronic Kidney Disease.
MDRD: Modification of Diet in Renal Disease.
CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration.
* p value was calculated using a paired t-test.
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Figure 2 Distributions of measured GFR and estimated GFRs using a kernel density distribution. CKD: Chronic Kidney Disease; CKD-EPI:
Chronic Kidney Disease Epidemiology Collaboration; eGFR: estimated GFR; GFR: Glomerular Filtration rate; MDRD: Modification of Diet in Renal
Disease. Results of GFR are expressed as mL/min/1.73 m2.
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1.159 for the CKD-EPI equation [12] is based on studies
performed in African-Americans. It has not been vali-
dated in black people of other ethnic origin, nor at
extremes of body weight [8]. It has recently been shown
that the CKD-EPI equation without adjustment for eth-
nicity is the most useful equation to estimate GFR in a
lean Sub-Saharan African population [19] which may
share some characteristics with adult SCD populations.
Moreover, in a study of one hundred black South Afri-
cans, Van Deventer et al.. have reported that both the
MDRD-v4 [20] and the CKD-EPI [21] equations overes-
timated GFR when using the ethnicity correction factor
as suggested for African-Americans. Among the patients
they studied, fifteen had a BMI < 20 kg/m2 and their me-
dian weight and BSA were 67 kg and 1.75 m2 respect-
ively. In our study, the unexpected improvement of the
performance of the MDRD and CKD-EPI equations
without adjustment for ethnicity to estimate GFR could
be explained by the fact that our patients had lower BMI
compared to the one of the patients tested in MDRD
and CKD-EPI samples since the mean body weight was
79.6 kg in the MDRD study [11] and 82 kg in the CKD-
EPI study [12]. Another explanation could be that meat
intake [22] may be lower in our population than in the
African-American one. It was also shown that African-
Americans had greater serum creatinine levels and urin-
ary creatinine excretion for any given GFR compared to
non-African-Americans [23]. Finally, the MDRD and
CKD-EPI equations were developed in patients with
chronic kidney disease stage 4–5. The study of Peralta
et al.. [24] strongly suggests that even in a cohort of Af-
rican-American, the race correction factors of 1.21 for
the MDRD-v4 et 1.16 for the CKD-EPI equations are
probably too high for young patients with CKD-EPI esti-
mated GFR comprised between 60 and 80 mL/min/
1.73 m2 and should rather be 1.12.
Determining the best equation for GFR estimation is
of great importance, especially for the care of SCD
patients living in developing areas where GFR measure-
ment is not easily accessible. Our results, as well as
those of other studies [19,21], claim for the use of more
specific equations to estimate GFR according to the sub-
population tested. Most online formulas for calculating
estimated GFR using the MDRD-v4 or CKD-EPI equa-
tions propose to choose between “black skin” and “non
black skin” or between “African origin” and “non-
African origin”, whereas they should offer the choice of
“African-American” versus “non- African-American
origin”.
In the case of SCD patients, screening for GFR level
and especially for glomerular hyperfiltration status is of
paramount importance, given its association with
microalbuminuria or macroalbuminuria [5,25,26]. As
previously explained, we chose to define glomerular
hyperfiltration as mGFR higher than 110 mL/min/
1.73 m2, as did Haymann et al. [5]. Using this controver-
sial definition, glomerular hyperfiltration seems to be a
very frequent finding in young adult SCD patients: in
our study, 68% of patients with SS-genotype had glom-
erular hyperfiltration, similar to the 66% of 48 homozy-
gous SCD patients reported previously for whom GFR
was measured using urinary 51Cr EDTA method [5].
Moreover, in our patients’ population, we demonstrated
that the urinary albumin/creatinine ratio significantly
increased when mGFR was above 112 mL/mn/1.73 m2.
Since we showed that mGFR non-indexed for BSA was
comparable to mGFR expressed per BSA, we can assert
that the putative hyperfiltration status is not an artifact
linked to BSA indexation in our population. Indeed BSA
indexation is questionable especially in subjects with
low BMI [27,28]. However, both the MDRD and CKD-
EPI equations automatically estimate GFR expressed per
BSA, so that we could not express estimated and mea-
sured GFRs without this indexation.
One of the limitations of our study could lie in the
lack of homogeneity of our population since we chose to
pool the SCD patients with SS and non-SS genotypes.
However, although the patients with hemoglobin SS had
a more severe disease than those with other sickling
hemoglobinopathies, the measurement properties of the
five equations tested were similar in SCD patients with
or without the SS genotype. Ideally, the validity of the
CKD-EPI equation without the adjustment for African-
American ethnicity should have been assessed in a con-
trol group comprising individuals of the same ethnic ori-
gin but with an AA genotype test to allow us to claim
that hyperfiltration was specific to SCD but this last
point was not the main goal of our study. Moreover,
Thompson et al.. already have already shown that SCD
patients have higher GFR as well as higher urinary albu-
min to creatinine ratio than controls [29].
Another limitation of our study is the definition of
hyperfiltration. We chose to consider that a measured
GFR higher than 110 mL/min/1.73 m2 defines hyper-
filtration for two reasons: first, this definition is the
one given by Haymann et al.. in their recent work
about GFR in SCD patients [5] and we wished to
compare our results to theirs; secondly, although this
arbitrary level may be considered as too low, we
observed that in our population, urinary albumin ex-
cretion was the lowest when mGFR was between 96
and 112 mL/min/1.73 m2, whereas urinary albumin
excretion significantly increased when mGFR was
higher than112 mL/min/1.73 m2. Consequently a
mGFR higher than 110 mL/min/1.73 m2 may be con-
sidered as pathological in this population as it is
more frequently associated with the presence of micro
or macroalbuminuria.
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Conclusions
Our study confirms that SCD patients have a high rate
of glomerular hyperfiltration, which is frequently asso-
ciated with microalbuminuria or macroalbuminuria and
shows that in SCD patients of non African-American
origin, the CKD-EPI equation without adjustment for
ethnicity should be the recommended method to esti-
mate GFR.
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